BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17552551)

  • 1. Verification of endometrial tissue biomarkers previously discovered using mass spectrometry-based proteomics by means of immunohistochemistry in a tissue microarray format.
    Dubé V; Grigull J; DeSouza LV; Ghanny S; Colgan TJ; Romaschin AD; Siu KW
    J Proteome Res; 2007 Jul; 6(7):2648-55. PubMed ID: 17552551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarker proteins released by human endometrial and cervical cancer cells using two-dimensional liquid chromatography/tandem mass spectrometry.
    Li H; DeSouza LV; Ghanny S; Li W; Romaschin AD; Colgan TJ; Siu KW
    J Proteome Res; 2007 Jul; 6(7):2615-22. PubMed ID: 17523614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer.
    DeSouza LV; Romaschin AD; Colgan TJ; Siu KW
    Anal Chem; 2009 May; 81(9):3462-70. PubMed ID: 19323455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues.
    DeSouza LV; Taylor AM; Li W; Minkoff MS; Romaschin AD; Colgan TJ; Siu KW
    J Proteome Res; 2008 Aug; 7(8):3525-34. PubMed ID: 18630974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry.
    DeSouza LV; Grigull J; Ghanny S; Dubé V; Romaschin AD; Colgan TJ; Siu KW
    Mol Cell Proteomics; 2007 Jul; 6(7):1170-82. PubMed ID: 17374602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer.
    Steinbakk A; Skaland I; Gudlaugsson E; Janssen EA; Kjellevold KH; Klos J; Løvslett K; Fiane B; Baak JP
    Am J Obstet Gynecol; 2009 Jan; 200(1):78.e1-8. PubMed ID: 18976730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking for Thom's biomarkers with proteomics.
    Drukier AK; Grigoriev I; Brown LR; Tomaszewski JE; Sainsbury R; Godovac-Zimmermann J
    J Proteome Res; 2006 Aug; 5(8):2046-8. PubMed ID: 16889429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues.
    DeSouza LV; Krakovska O; Darfler MM; Krizman DB; Romaschin AD; Colgan TJ; Siu KW
    Proteomics; 2010 Sep; 10(17):3108-16. PubMed ID: 20661955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
    Camp RL; Neumeister V; Rimm DL
    J Clin Oncol; 2008 Dec; 26(34):5630-7. PubMed ID: 18936473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.
    Zhu H; Pei HP; Zeng S; Chen J; Shen LF; Zhong MZ; Yao RJ; Shen H
    J Proteome Res; 2009 Aug; 8(8):3969-76. PubMed ID: 19507834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker validation: in situ analysis of protein expression using semiquantitative immunohistochemistry-based techniques.
    Sullivan CA; Chung GG
    Clin Colorectal Cancer; 2008 May; 7(3):172-7. PubMed ID: 18621634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry.
    Garbis SD; Tyritzis SI; Roumeliotis T; Zerefos P; Giannopoulou EG; Vlahou A; Kossida S; Diaz J; Vourekas S; Tamvakopoulos C; Pavlakis K; Sanoudou D; Constantinides CA
    J Proteome Res; 2008 Aug; 7(8):3146-58. PubMed ID: 18553995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of a sample preparation and analytical workflow for proteomics of archival endometrial cancer tissue.
    Alkhas A; Hood BL; Oliver K; Teng PN; Oliver J; Mitchell D; Hamilton CA; Maxwell GL; Conrads TP
    J Proteome Res; 2011 Nov; 10(11):5264-71. PubMed ID: 21932769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.